Prognostic Factors in Squamous Cell Carcinoma of the Vulva: a Retrospective Multicenter Study

被引：0

作者：

Kuru, Oguzhan ^{[1
]}

Akgor, Utku ^{[2
]}

Cakir, Ilker ^{[1
]}

Tosun, Ozgur ^{[3
]}

Yuksel, Ilkbal Temel ^{[4
]}

Ulker, Volkan ^{[4
]}

Meydanli, Mutlu ^{[5
]}

Sanci, Muzaffer ^{[1
]}

Gokcu, Mehmet ^{[1
]}

Topuz, Samet ^{[3
]}

Yildiz, Ferah ^{[6
]}

Sakinci, Mehmet ^{[7
]}

Salman, Mehmet Coskun ^{[2
]}

Ozgul, Nejat ^{[2
]}

Yuce, Kunter ^{[2
]}

Ayhan, Ali ^{[8
]}

机构：

[1] Izmir Tepecik Training & Res Hosp, Dept Gynecol Oncol, Izmir, Turkey

[2] Hacettepe Univ, Fac Med, Dept Gynecol Oncol, TR-06100 Ankara, Turkey

[3] Istanbul Univ, Fac Med, Dept Gynecol Oncol, Istanbul, Turkey

[4] Kanuni Sultan Suleyman Training & Res Hosp, Dept Gynecol Oncol, Istanbul, Turkey

[5] Zekai Tahir Burak Womens Hlth Training & Res Hosp, Dept Gynecol Oncol, Ankara, Turkey

[6] Hacettepe Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkey

[7] Akdeniz Univ, Dept Obstet & Gynecol, Fac Med, Antalya, Turkey

[8] Baskent Univ, Fac Med, Dept Gynecol Oncol, Ankara, Turkey

来源：

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI | 2020年 / 30卷 / 01期

关键词：

Metformin; Prognosis; Recurrence; Survival; Vulvar cancer; MARGIN DISTANCE; CANCER; RECURRENCE; PATTERNS; METFORMIN; SURVIVAL; DRUG;

D O I：

10.4999/uhod.204053

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The study aim to determine the clinicopathological factors for disease-free survival (DFS) and overall survival (OS) in women with vulvar cancer and to analyze the the possible effect of metformin on survival of the patients. From 2011 to 2017, medical records of 142 patients who underwent primary radical surgery for VC at 6 referral centers in Turkey were collected, retrospectively. The median age of the cohort was 67.0 years. 124 patients underwent radical surgery and inguinofemoral lymphadenectomy. The overall recurrence rate was 33.8% within a median follow-up time of 22 months. Five-year DFS and OS rates were 55.8% and 62.6%, respectively. Multivariate analysis showed surgical margin (HR:6.4, p= 0.017 for DFS; HR: 13.6, p=0.009 for OS) and lymph node metastasis (HR: 4.1, p= 0.014 for DFS; HR: 6.3, p= 0.020 for OS) were the independent prognostic factors. There was no statistically difference in DFS and OS for patients who had used metformin.

引用

页码：54 / 62

页数：9

共 50 条

[21] Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
Mirabile, Aurora
Miceli, Rosalba
Calderone, Rosa Gioia
Locati, Laura
Bossi, Paolo
Bergamini, Cristiana
Granata, Roberta
Perrone, Federica
Mariani, Luigi
Licitra, Lisa
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1895 - 1902
[22] Patterns of recurrence in patients with squamous cell carcinoma of the vulva -: A multicenter CTF study
Maggino, T
Landoni, F
Sartori, E
Zola, P
Gadducci, A
Alessi, C
Soldà, M
Coscio, S
Spinetti, G
Maneo, A
Ferrero, A
de Toffoli, GK
CANCER, 2000, 89 (01) : 116 - 122
[23] Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy
Gadducci, A.
Ferrero, A.
Tana, R.
Fabrini, M. G.
Modaffari, P.
Fanucchi, A.
Vignati, C.
Zola, P.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (06) : 640 - 643
[24] Cytoplasmic expression of oestrogen receptor beta (ERß) as a prognostic factor in vulvar squamous cell carcinoma in elderly women
Zannoni, Gian F.
Prisco, Maria G.
Vellone, Valerio G.
De Stefano, Ilaria
Vizzielli, Giuseppe
Tortorella, Lucia
Fagotti, Anna
Scambia, Giovanni
Gallo, Daniela
HISTOPATHOLOGY, 2011, 59 (05) : 909 - 917
[25] Prognostic factors of oral squamous cell carcinoma: the importance of recurrence and pTNM stage
Kim, Min Jae
Ahn, Kang-Min
MAXILLOFACIAL PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 46 (01)
[26] Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients
Saito, Yuki
Fujikawa, Hiroki
Takatsuka, Sumiko
Abe, Riichiro
Takenouchi, Tatsuya
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 606 - 612
[27] Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma
Yamakawa, Nobuhiro
Umeda, Masahiro
Yoshii, Yumi
Mitsudo, Kenji
Noguchi, Makoto
Kusukawa, Jingo
Katakura, Akira
Nakayama, Hideki
Sasaki, Masashi
Noguchi, Tadahide
Ueda, Michihiro
Bukawa, Hiroki
Yagihara, Kazuhiro
Horie, Akihisa
Miyazaki, Akihiro
Chikazu, Daichi
Tomihara, Kei
Mishima, Katsuaki
Otsuru, Mitsunobu
Asoda, Seiji
Fujiwara, Shigeyoshi
Ohyama, Yoshio
Kurita, Hiroshi
Kawamata, Hitoshi
Fukuda, Masayuki
Shintani, Yukari
Kobayashi, Takanori
Kanno, Takahiro
Oh-Iwa, Ichiro
Kawano, Kenji
Yamashita, Yoshio
Kobayashi, Wataru
Ohiro, Yoichi
Uzawa, Katsuhiro
Ota, Yoshihide
Kirita, Tadaaki
ORAL DISEASES, 2024, 30 (02) : 247 - 258
[28] Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors
Kapacee, Z. A.
Susnerwala, S.
Wise, M.
Biswas, A.
Danwata, F.
Scott, N.
COLORECTAL DISEASE, 2016, 18 (11) : 1080 - 1086
[29] The role of pathologic prognostic factors in squamous cell carcinoma of the penis
Cubilla, Antonio L.
WORLD JOURNAL OF UROLOGY, 2009, 27 (02) : 169 - 177
[30] A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study
Wu, Lei-Lei
Ma, Qi-Long
Huang, Wei
Liu, Xuan
Qiu, Li-Hong
Lin, Peng
Long, Hao
Zhang, Lan-Jun
Ma, Guo-Wei
BMC GASTROENTEROLOGY, 2021, 21 (01)

← 1 2 3 4 5 →